Literature DB >> 22610045

Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers.

M R Williams1, R Chaudhry, S Perera, R K B Pearce, S R Hirsch, O Ansorge, M Thom, M Maier.   

Abstract

Decreased cortical thickness and reduced activity as measured by fMRI in the grey matter of the subgenual cingulate cortex have been reported in schizophrenia and bipolar disorder, and cortical grey matter loss has been reliably reported in the frontal and temporal lobes in schizophrenia. The aim of this study was to examine the thickness of each of the six cortical layers in the subgenual cingulate cortex, five frontal lobe and four temporal lobe gyri. We examined two separate cohorts. Cohort 1 examines the subgenual cingulate cortex (SCC) in schizophrenia (n = 10), bipolar disorder (n = 15) and major depressive disorder (n = 20) against control subjects (n = 19). Cohort two examines frontal and temporal gyri in schizophrenia (n = 16), major depressive disorder (n = 6) against matched controls (n = 32). The cohorts were selected with identical clinical criteria, but underwent different tissue processing to contrast the effect of chemical treatment on tissue shrinkage. Measurements of layer I-VI thickness were taken from cresyl-violet- and haematoxylin-stained sections in cohort one and from cresyl-violet- and H&E-stained sections in cohort two. SCC cortical thickness decreased in male subjects with bipolar disorder (p = 0.048), and male schizophrenia cases showed a specific decrease in the absolute thickness of layer V (p = 0.003). Compared to controls, the relative thickness of layer V in the crown of the SCC decreased in schizophrenia (p < 0.001). A significant decrease in total cortical thickness was observed across the frontal lobe in schizophrenia (p < 0.0001), with specific pyramidal layer thinning in layers III (p = 0.0001) and V (p = 0.005). There was no effect of lateralization. No changes were noted in temporal lobe cortical thickness. This study demonstrates diminished pyramidal layer thickness resulting in decreased frontal lobe thickness in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610045     DOI: 10.1007/s00406-012-0325-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  68 in total

1.  Cortical thickness, neuron density and size in the inferior parietal lobe in schizophrenia.

Authors:  John F Smiley; Kira Konnova; Cynthia Bleiwas
Journal:  Schizophr Res       Date:  2012-02-02       Impact factor: 4.939

2.  Inhibitory cartridge synapses in the anterior cingulate cortex of schizophrenics.

Authors:  P Kalus; D Senitz; M Lauer; H Beckmann
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

3.  Neuropathology of epilepsy and psychosis: the contributions of J.A.N. Corsellis.

Authors:  Burkhard S Kasper; David C Taylor; Dieter Janz; Ekkehard M Kasper; Michael Maier; Matthew R Williams; Timothy J Crow
Journal:  Brain       Date:  2010-09-03       Impact factor: 13.501

4.  Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia.

Authors:  P E Barta; G D Pearlson; R E Powers; S S Richards; L E Tune
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

5.  Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter.

Authors:  C C Dickey; R W McCarley; M M Voglmaier; M A Niznikiewicz; L J Seidman; Y Hirayasu; I Fischer; E K Teh; R Van Rhoads; M Jakab; R Kikinis; F A Jolesz; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-06-01       Impact factor: 13.382

6.  A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain.

Authors:  Mark S Todtenkopf; Stephen L Vincent; Francine M Benes
Journal:  Schizophr Res       Date:  2005-02-01       Impact factor: 4.939

Review 7.  Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions.

Authors:  S Levin
Journal:  J Psychiatr Res       Date:  1984       Impact factor: 4.791

8.  Are schizophrenic men at higher risk for developmental deficits than schizophrenic women? Implications for adult neuropsychological functions.

Authors:  J M Goldstein; L J Seidman; S Santangelo; P H Knapp; M T Tsuang
Journal:  J Psychiatr Res       Date:  1994 Nov-Dec       Impact factor: 4.791

9.  Progression of brain volume changes in adolescent-onset psychosis.

Authors:  Santiago Reig; Carmen Moreno; Dolores Moreno; Maite Burdalo; Joost Janssen; Mara Parellada; Arantzazu Zabala; Manuel Desco; Celso Arango
Journal:  Schizophr Bull       Date:  2008-01-24       Impact factor: 9.306

10.  [Neuropathology of schizophrenias].

Authors:  B Bogerts
Journal:  Fortschr Neurol Psychiatr       Date:  1984-12       Impact factor: 0.752

View more
  14 in total

1.  Association of a risk allele of ANK3 with cognitive performance and cortical thickness in patients with first-episode psychosis.

Authors:  Clifford Cassidy; Lisa Buchy; Michael Bodnar; Jennifer Dell'elce; Zia Choudhry; Ferid Fathalli; Sarojini Sengupta; Rebecca Fox; Ashok Malla; Martin Lepage; Srividya Iyer; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

2.  Schizophrenia: brain morphology and treatment aspects.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02       Impact factor: 5.270

3.  Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia.

Authors:  Yuan Xiao; Su Lui; Wei Deng; Li Yao; Wenjing Zhang; Shiguang Li; Min Wu; Teng Xie; Yong He; Xiaoqi Huang; Junmei Hu; Feng Bi; Tao Li; Qiyong Gong
Journal:  Schizophr Bull       Date:  2013-12-18       Impact factor: 9.306

4.  AgRP neurons control structure and function of the medial prefrontal cortex.

Authors:  Bernardo Stutz; Michael J Waterson; Matija Šestan-Peša; Marcelo O Dietrich; Mario Škarica; Nenad Sestan; Bence Racz; Aletta Magyar; Peter Sotonyi; Zhong-Wu Liu; Xiao-Bing Gao; Ferenc Matyas; Milan Stoiljkovic; Tamas L Horvath
Journal:  Mol Psychiatry       Date:  2022-07-29       Impact factor: 13.437

5.  Neuropathological changes in the nucleus basalis in schizophrenia.

Authors:  M R Williams; R Marsh; C D Macdonald; J Jain; R K B Pearce; S R Hirsch; O Ansorge; S M Gentleman; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-12-11       Impact factor: 5.270

6.  Surface-based laminar analysis of diffusion abnormalities in cortical and white matter layers in neocortical epilepsy.

Authors:  Rajkumar Munian Govindan; Eishi Asano; Csaba Juhasz; Jeong-Won Jeong; Harry T Chugani
Journal:  Epilepsia       Date:  2013-02-28       Impact factor: 5.864

7.  Deletion of collapsin response mediator protein 4 results in abnormal layer thickness and elongation of mitral cell apical dendrites in the neonatal olfactory bulb.

Authors:  Atsuhiro Tsutiya; Hikaru Watanabe; Yui Nakano; Masugi Nishihara; Yoshio Goshima; Ritsuko Ohtani-Kaneko
Journal:  J Anat       Date:  2016-01-06       Impact factor: 2.610

8.  Asymmetry in Cortical and Subcortical Structures of the Brain in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Authors:  Sijian Chen; Lin Guan; Jie Tang; Fan He; Yi Zheng
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-12       Impact factor: 2.570

9.  Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations.

Authors:  Yuan Xiao; Wei Liao; Zhiliang Long; Bo Tao; Qiannan Zhao; Chunyan Luo; Carol A Tamminga; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Elena I Ivleva; Sarah K Keedy; Bharat B Biswal; Andrea Mechelli; Rebekka Lencer; John A Sweeney; Su Lui; Qiyong Gong
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

10.  Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia.

Authors:  Matthew Williams; Ronald K B Pearce; Steven R Hirsch; Olaf Ansorge; Maria Thom; Michael Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-12-29       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.